Document is current
Any future updates will be listed below
-
Authors
Marchetti, Michael A.
Cowen, Emily A. https://orcid.org/0000-0002-8616-3542
Kurtansky, Nicholas R. https://orcid.org/0000-0002-6745-0386
Weber, Jochen https://orcid.org/0000-0002-2397-4954
Dauscher, Megan
DeFazio, Jennifer
Deng, Liang
Dusza, Stephen W.
Haliasos, Helen
Halpern, Allan C.
Hosein, Sharif
Nazir, Zaeem H. https://orcid.org/0000-0001-7652-8512
Marghoob, Ashfaq A. https://orcid.org/0000-0001-6068-0114
Quigley, Elizabeth A.
Salvador, Trina
Rotemberg, Veronica M. https://orcid.org/0000-0003-0639-2677
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748, P30 CA008748)
Harry J. Lloyd Charitable Trust (n/a, n/a)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (2KL2-TR-2385)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 17 February 2023
Accepted: 26 June 2023
First Online: 12 July 2023
Competing interests
: V.R. is an expert advisor for Inhabit Brands. A.H. consults for Canfield Scientific Inc. and Janssen Research and Development, has ownership/equity interests in HCW Health LLC, SKIP Derm LLC, and has a fiduciary role/position and intellectual rights in SKIP Derm LLC. A.M. reports receiving honorarium from Canfield Scientific Inc. All other authors declare no competing interests.
